Robleto D O, Herman C A
Department of Biology, New Mexico State University, Las Cruces 88005.
J Exp Zool. 1988 Apr;246(1):10-6. doi: 10.1002/jez.1402460103.
The cardiovascular effects of prostaglandin (PG)I2 and PGF2 alpha were compared in the unanesthetized American bullfrog (Rana catesbeiana). Control mean arterial pressure (MAP) and heart rate (HR) were 25.7 +/- 1.1 mm Hg and 35.1 +/- 1.1 beats/min, respectively. Intravenous injections of PGI2 decreased MAP and increased HR in a dose-dependent fashion over the range of concentrations tested (0.03, 0.3, 3, and 10 micrograms/kg-body weight [bw]. Neither atropine (1 mg/kg-bw) nor verapamil (1 mg/kg-bw) treatment altered the MAP or HR responses to PGI2 (3 micrograms/kg-bw). However, propranolol (5 mg/kg-bw) significantly blunted the hypotensive effects without affecting the increase in HR. Prostaglandin F2 alpha (tested at 0.3, 3, 30, and 100 micrograms/kg-bw) increased both MAP and HR. Mean arterial pressure increased with concentrations greater than 0.3 microgram/kg-bw and reached peak effects at 30 micrograms/kg-bw. Prostaglandin F2 alpha increased HR at doses greater than 0.3 microgram/kg-bw. Neither the pressor nor positive chronotropic effects of PGF2 alpha (30 micrograms/kg-bw) were affected by atropine or propranolol. However, verapamil significantly attenuated the pressor effects without affecting the increase in HR. These results demonstrate that both prostaglandins have qualitatively similar effects on HR, but opposite effects on MAP. Prostaglandin I2 is a hypotensive prostaglandin, while PGF2 alpha is hypertensive. The pressor effects of PGF2 alpha are partially dependent on calcium influx. The positive chronotropic effects of both prostaglandins are independent of the autonomic nervous system, suggesting a different mechanism of action.
在未麻醉的美国牛蛙(牛蛙)中比较了前列腺素(PG)I2和PGF2α的心血管效应。对照平均动脉压(MAP)和心率(HR)分别为25.7±1.1 mmHg和35.1±1.1次/分钟。在测试的浓度范围内(0.03、0.3、3和10微克/千克体重[bw]),静脉注射PGI2以剂量依赖性方式降低MAP并增加HR。阿托品(1毫克/千克体重)和维拉帕米(1毫克/千克体重)治疗均未改变对PGI2(3微克/千克体重)的MAP或HR反应。然而,普萘洛尔(5毫克/千克体重)显著减弱了降压作用,而不影响HR的增加。前列腺素F2α(在0.3、3、30和100微克/千克体重下测试)增加了MAP和HR。平均动脉压在浓度大于0.3微克/千克体重时升高,并在30微克/千克体重时达到峰值效应。前列腺素F2α在剂量大于0.3微克/千克体重时增加HR。阿托品或普萘洛尔均不影响PGF2α(30微克/千克体重)的升压或正性变时作用。然而,维拉帕米显著减弱了升压作用,而不影响HR的增加。这些结果表明,两种前列腺素对HR具有定性相似的作用,但对MAP具有相反的作用。前列腺素I2是一种降压前列腺素,而PGF2α是升压的。PGF2α的升压作用部分依赖于钙内流。两种前列腺素的正性变时作用均独立于自主神经系统,提示作用机制不同。